The Online Marketplace for Human Biospecimens
Transforming Biospecimen Procurement
March 2024
Investor Presentation
Nasdaq: ISPC
Forward-Looking Statements
This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," "believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward- looking information. Such statements are only predictions and our actual results may differ materially from those anticipated in these forward-looking statements.
We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Factors that may cause such differences include, but are not limited to, those discussed under Risk Factors in our filings filed with the Securities and Exchange Commission (the "SEC"), including the uncertainties associated with our lack of profitability, our continued capital needs, our lack of a long operating history, our growth strategy, the uncertain effect of geopolitical developments, our technology development plans, and the regulatory environment in which we operate. We do not assume any obligation to update forward-looking statements as circumstances change.
Certain market data information in this presentation is based on management's estimates. We obtained the industry, market and competitive position data used throughout this presentation from internal estimates and research as well as from industry publications and research, surveys and studies conducted by third parties. We believe our estimates to be accurate as of the
date of this presentation. However, this information may prove to be inaccurate because of the method by which we obtained
some of the data for our estimates or because this information cannot always be verified due to the limits on the availability and reliability of raw data, and the nature of the data gathering process.
You may access our SEC filings by visiting the SEC's website at http://www.sec.gov. This presentation does not constitute an offer or invitation for the sale or purchase of securities or to engage in any other transaction with us or our affiliates. The information in this presentation is not targeted at the residents of any particular country or jurisdiction and is not intended for distribution to, or use by, any person in any jurisdiction or country where such distribution or use would be contrary to local law
or regulation.
2
Our Vision
To transform the biospecimen industry with an online marketplace connecting researchers to patients, biospecimens, and data, through our global network.
3
Investor Highlights
- Similar to Amazon, iSpecimen has developed an online marketplace to seamlessly connect researchers with healthcare providers and supplier organizations
- First mover advantage that addresses an inefficient and fragmented global biospecimen supply chain that is poised to be disrupted by an online solution
- $3B-$4Bglobal biospecimen market growing at 10-15%per year 1,2
- Strong revenue growth with an 8-year CAGR of 39% fueled by precision and regenerative medicine research
- Plans to enhance existing platform and develop new service offering to increase revenue opportunities
>220
Healthcare Provider / Supplier
Organizations
>600
Customer
Organizations
1,2 "Sources Cited" page 31
Biospecimens are Essential for Life Science R&D
SUPPLY SIDE
HEALTHCARE PROVIDERS
DEMAND SIDE
LIFE SCIENCE RESEARCHERS
Patients | Biospecimens | Data |
Biofluids
Plasma, Serum, Urine, Saliva
Medical
Record
Solid Tissue
Lung, Breast, Colon, Brain
Stem & Immune Cells
Organizations
Industry
Academia
Applications
Basic Research
Biomarker
Identification &
Validation
Drug Discovery &
Development
Bone Marrow, Blood, Tonsils, Lymph Nodes
Government | Diagnostics | ||
Discovery & | |||
Validation | |||
5
Biospecimen Supply Chain Challenges
Providers miss revenue and
research opportunities
> 1 Billion
Patient encounters yearly in the U.S. where a specimen could be provided for research 3
> 3 Billion
clinical specimens are discarded
annually worldwide 4
> 800 Million
banked specimens are in biorepository
inventories worldwide 5
Researchers limit
their work
10 years ago, 81%
of researchers said they limit the scope of their work
due to difficulties obtaining biospecimens 6
… in 2022, 78%
of researchers said they find it difficult-to-extremely difficult to find
the type and quantity of specimens they need 7
"Challenging" and "Inefficient"
most common words used to describe biospecimen procurement process by researchers 7
3,4,5,6,7,8 "Sources Cited" page 31 | 6 |
Biospecimen Supply Chain Challenges
-Difficult to Connect, Search and Compliantly Transact -Average time to develop relationships is 6-12 months ᶟ
PROVIDERS | CHALLENGE | RESEARCHERS |
8 "Sources Cited" page 31 | 7 |
The iSpecimen Marketplace® Solution
-iSpecimen Customer Base: 70% of the Top 20 Pharma Companies and IVD Companies Worldwide
PROVIDERS | SOLUTION | RESEARCHERS |
8
Full-Service Procurement Offering
-Connect Suppliers with Researchers
-Manage the Entire Procurement Process
iSpecimen Services
CONTRACTING
COMPLIANCE MANAGEMENT
STUDY DESIGN & SPECIFICATION
SPECIMEN SEARCH & SELECTION
STUDY/ORDER MANAGEMENT
COLLECTION KIT BUILDING
SUPPLIER SITE TRAINING
SPECIMEN LOGISTICS
SPECIMEN MANAGEMENT
DATA MANAGEMENT
9
iSpecimen Value Proposition
Providers…
Monetize Banked Biospecimens
Instantly connect to a global network of researchers in search for biospecimens
Advance Scientific Discovery
Support research mission and advance diagnostic, therapeutic and vaccine research
Ensure Compliance
Protect the privacy and security of patient information
Researchers…
Save Time and Money
Instantly connect to global network of specimen providers
Accelerate Research
Search for specimens anytime, anywhere, through easy-to-use online marketplace
Reduce Risk
Manage contracting and regulatory compliance
10
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
iSpecimen Inc. published this content on 14 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 March 2024 12:51:18 UTC.